Reference: Bramante, C. T., Huling, J. D., Tignanelli, C. J., Buse, J. B., Liebovitz, D. M., Nicklas, J. M., Cohen, K., Puskarich, M. A., Belani, H. K., Proper, J. L., Siegel, L. K., Klatt, N. R., Odde, D. J., Luke, D. G., Anderson, B., Karger, A. B., Ingraham, N. E., Hartman, K. M., Rao, V., […]
Reference: Marik, P. E., Kory, P., & Contributors. (2022). I-RECOVER: Post-Vaccine Treatment protocol (5/25/2022). An Approach to the Management of Post-Vaccine Syndrome. Summary: The I-RECOVER protocol is designed to aid healthcare professionals in managing patients with post-vaccine syndrome, a condition arising from COVID-19 vaccinations. While no formal definition exists, symptoms correlating temporally with vaccination can
Reference: Kory, P., Marik, P., et al. (2022). I-RECOVER: Post-Vaccine Treatment protocol. Summary: The I-RECOVER protocol offers guidance for healthcare professionals treating patients experiencing post-vaccine syndrome, a condition with symptoms emerging or worsening following COVID-19 vaccination. Contributors, including prominent physicians, acknowledge the lack of formal recognition and classification for this syndrome by major health organisations,
Reference: Marik, P. (2022. COVID-19 management protocol. FLCCC Alliance. Retrieved from www.flccc.net Summary: The FLCCC Alliance’s COVID-19 Management Protocol, developed by Dr Paul Marik, outlines strategies for managing COVID-19 through three primary protocols: MATH+, I-MASK+, and I-RECOVER. The MATH+ protocol focuses on treating patients in the pulmonary phase, utilising anti-inflammatory therapies and corticosteroids to reduce
Reference: Reis, G., Silva, E. A. S. M., Silva, D. C. M., Thabane, L., Milagres, A. C., Ferreira, T. S., dos Santos, C. V. Q., Campos, V. H. S., Nogueira, A. M. R., de Almeida, A. P. F. G., Callegari, E. D., Neto, A. D. F., Savassi, L. C. M., Simplicio, M. I. C., Ribeiro,
Reference: FLCCC Alliance. (2021). I-MASK+ protocol: Prevention and early outpatient treatment protocol for COVID-19 (Version 18). Retrieved from https://www.flccc.net/covid-19-protocols Summary: The I-MASK+ protocol, developed by the Front Line COVID-19 Critical Care Alliance (FLCCC), is designed for the prevention and early outpatient treatment of COVID-19, particularly against the Delta variant. It emphasises the use of ivermectin
Reference: South African National Department of Health. (2021). Rapid review of Ivermectin for COVID-19: Evidence review of clinical benefits and harms (Update: 30 July 2021). Summary: The South African National Department of Health conducted a rapid review to assess the efficacy of ivermectin in treating COVID-19. The review, which synthesised findings from multiple randomised controlled
Reference: Search results obtained to compile a database of all the studies done on Ivermecting as therapeutic drug for COVID-19. 2021-07-18. Summary: Database of all Ivermectin COVID-19 studies. 101 studies, 66 peer reviewed, 60 with results comparing treatment and control groups. DOWNLOAD
Reference: Okahandja Community Forum. (2021, July 9). An Okahandja community project: What you can do at home. Summary: The Okahandja community project, initiated on 9 July 2021, provides guidance for individuals on how to manage health concerns related to Covid-19. Emphasising the importance of prevention and patient support, the document outlines necessary hygiene measures, such
Reference: Wucher, M. (2021). COVID-19 – Ask your doctor: What you should know today. Retrieved from [source link] Summary: Dr Martin Wucher’s guide offers critical insights into managing COVID-19, emphasising the importance of immune system readiness before, during, and after infection. He advises against self-medication and promotes seeking professional medical advice. The guide underscores the